Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
135.5 EUR | -0.94% | -1.98% | -3.40% |
02:34pm | J&J: acquisition of Swiss eczema biotech company | CF |
02:10pm | J&J to Acquire Skin Disease Treatment Rights from Numab in $1.25 Billion Deal | DJ |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- Revisions Johnson & Johnson